Advertisement
Advertisement
TOPIC
 / company

Mirxes

Mirxes
The latest news and top stories on Mirxes. A Singapore-headquartered entity in the biotechnology sector, Mirxes specialises in microRNA technology for early disease detection and precision medicine. It primarily serves global markets, particularly Asia, and is known for being Singapore’s first biotech unicorn and the first Southeast Asian biotech firm to list on the Hong Kong Stock Exchange.
Biomedicine: Companies

Mirxes wins China’s approval to launch groundbreaking gastric cancer blood test

The non-invasive blood test helps in the early detection of the fifth leading cause of cancer deaths globally.

Malaysian heiress to Top Glove fortune seeks US$200 million for private markets

Advertisement
Advertisement
Advertisement